Artiva Biotherapeutics (ARTV) Assets: 2023-2025
Historic Assets for Artiva Biotherapeutics (ARTV) over the last 2 years, with Sep 2025 value amounting to $148.9 million.
- Artiva Biotherapeutics' Assets fell 34.01% to $148.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $148.9 million, marking a year-over-year decrease of 34.01%. This contributed to the annual value of $209.6 million for FY2024, which is 99.38% up from last year.
- Per Artiva Biotherapeutics' latest filing, its Assets stood at $148.9 million for Q3 2025, which was down 12.12% from $169.4 million recorded in Q2 2025.
- In the past 5 years, Artiva Biotherapeutics' Assets registered a high of $225.6 million during Q3 2024, and its lowest value of $75.9 million during Q2 2024.
- In the last 3 years, Artiva Biotherapeutics' Assets had a median value of $169.4 million in 2025 and averaged $160.8 million.
- The largest annual percentage gain for Artiva Biotherapeutics' Assets in the last 5 years was 123.14% (2025), contrasted with its biggest fall of 34.01% (2025).
- Artiva Biotherapeutics' Assets (Quarterly) stood at $105.1 million in 2023, then skyrocketed by 99.38% to $209.6 million in 2024, then slumped by 34.01% to $148.9 million in 2025.
- Its last three reported values are $148.9 million in Q3 2025, $169.4 million for Q2 2025, and $191.3 million during Q1 2025.